Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Ingham

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Molecular Cancer Therapeutics|September 23, 2021
Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic InhibitorsTahir N Sheikh, Xiao Chen, Xinjing Xu, et al.
Oncotarget|April 2, 2021
Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinomaCharles R Schutt, Hua Sun, Jaya Sarin Pradhan, et al.
Current Treatment Options in Oncology|March 11, 2022
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?Bernd Kasper, Lorenzo D'Ambrosio, Elizabeth J Davis, et al.
Biochemical and Biophysical Research Communications|November 26, 2008
Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated proteinChristopher Looze, David Yui, Lester Leung, et al.
Biochemical and Biophysical Research Communications|December 15, 2007
Circulating TNFR1 exosome-like vesicles partition with the LDL fraction of human plasmaJing Zhang, Feras I Hawari, Robert D Shamburek, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipientsMegan H Trager, Shana M Coley, Geoffrey Dube, et al.
Chest|November 7, 2022
A 52-Year-Old Man With Chest Pain and DyspneaCharles G Murphy, Jonathan M Goldstein, Sepideh Besharati, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Systematic elucidation and pharmacologic targeting on non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumorPrabhjot S Mundi, Adina Grunn, Arsenije Kojadinovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2024
Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint BlockadeKaran Luthria, Parin Shah, Blake Caldwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2022
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated LiposarcomaMatthew Ingham, Shing Lee, Brian A Van Tine, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|September 23, 2021
Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic InhibitorsTahir N Sheikh, Xiao Chen, Xinjing Xu, et al.
Oncotarget|April 2, 2021
Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinomaCharles R Schutt, Hua Sun, Jaya Sarin Pradhan, et al.
Current Treatment Options in Oncology|March 11, 2022
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?Bernd Kasper, Lorenzo D'Ambrosio, Elizabeth J Davis, et al.
Biochemical and Biophysical Research Communications|November 26, 2008
Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated proteinChristopher Looze, David Yui, Lester Leung, et al.
Biochemical and Biophysical Research Communications|December 15, 2007
Circulating TNFR1 exosome-like vesicles partition with the LDL fraction of human plasmaJing Zhang, Feras I Hawari, Robert D Shamburek, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipientsMegan H Trager, Shana M Coley, Geoffrey Dube, et al.
Chest|November 7, 2022
A 52-Year-Old Man With Chest Pain and DyspneaCharles G Murphy, Jonathan M Goldstein, Sepideh Besharati, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Systematic elucidation and pharmacologic targeting on non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumorPrabhjot S Mundi, Adina Grunn, Arsenije Kojadinovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2024
Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint BlockadeKaran Luthria, Parin Shah, Blake Caldwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2022
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated LiposarcomaMatthew Ingham, Shing Lee, Brian A Van Tine, et al.
Pageof 4